Medicine and Dentistry
Atrial Fibrillation
72%
Catheter Ablation
53%
Heart Failure
51%
Tachyarrhythmia
27%
Supraventricular Tachycardia
27%
Catheter Ablation
26%
Systolic Heart Failure
26%
Ventricular Tachycardia
25%
Mitral Valve Disease
24%
Cardiology
24%
Transesophageal Echocardiography
22%
Ejection Fraction
22%
Chronic Atrial Fibrillation
21%
Recurrent Disease
20%
Heart Rate Variability
19%
Electrocardiogram
18%
Atrial Flutter
17%
Atrioventricular Node
17%
Brugada Syndrome
15%
Sinus Rhythm
15%
Congestive Heart Failure
14%
Coronary Artery Disease
14%
Ventricular Fibrillation
14%
Disease
14%
Atrioventricular Nodal Reentry Tachycardia
13%
Heart Disease
13%
Echocardiography
12%
Cardiac Magnetic Resonance Imaging
12%
Mitral Insufficiency
12%
Implantable Automatic Defibrillator
12%
Diastolic Dysfunction
12%
Cardiac Resynchronization Therapy
11%
Heart Left Ventricle Ejection Fraction
11%
Accessory Pathway
11%
Diastolic Heart Failure
11%
Cardiovascular Disease
11%
Blood Pressure
11%
Beta Adrenergic Receptor Blocking Agent
11%
Angiotensin Receptor Antagonist
10%
Cardiac Dysrhythmia
10%
Faintness
10%
Heart Atrium Pacing
10%
Cardioversion
10%
Drug Therapy
9%
Ischemic Heart Disease
9%
Sudden Cardiac Death
9%
Mitral Valve
9%
Atrium
9%
Coronary Sinus
9%
Radiofrequency Ablation
9%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Radiofrequency
27%
Gene Polymorphism
21%
Single-Nucleotide Polymorphism
21%
Tachycardia
20%
Tachyarrhythmia
20%
Renin Angiotensin Aldosterone System
19%
Angiotensin
16%
Heart Atrium Pacing
15%
Supraventricular Tachycardia
15%
Brugada Syndrome
14%
Electrocardiogram
13%
Cardiac Dysrhythmia
13%
C-Reactive Protein
12%
Genetics
12%
Haplotype
11%
Ventricular Tachycardia
11%
Angiotensin-Converting Enzyme
10%
Allele
10%
Promoter Region
10%
Genotyping
9%
Prevalence
8%
ATPase
8%
Ventricular Fibrillation
8%
Molecular Genetics
7%
Isomerism
7%
Receptor Gene
7%
Messenger RNA
7%
Accessory Pathway
7%
Genetic Polymorphism
6%
Repolarization
6%
Gene Interaction
6%
Potassium Channel
6%
Long QT Syndrome
6%
Action Potential Duration
6%
Heart Rate Variability
6%
Sodium Channel
6%
Neovison Vison
6%
Fibroblast
6%
Statin
6%
N-Terminus
5%
Heart Ejection Fraction
5%
Animal Model
5%
Denaturing High Performance Liquid Chromatography
5%
Aldosterone
5%
Transforming Growth Factor
5%
Genetic Divergence
5%
Natriuretic Peptide
5%
STAT3
5%
Platelet
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
71%
Heart Failure
38%
Congestive Heart Failure
19%
End Stage Renal Disease
16%
Angiotensin Receptor Antagonist
16%
Beta Adrenergic Receptor Blocking Agent
15%
Systolic Heart Failure
13%
Heart Infarction
13%
Coronary Artery Disease
13%
Statin (Protein)
13%
Tachycardia
12%
Cardiovascular Disease
12%
Recurrent Disease
12%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Metabolic Syndrome X
10%
C Reactive Protein
9%
Brugada Syndrome
9%
Heart Ventricle Tachycardia
8%
Heart Failure with Reduced Ejection Fraction
8%
Normal Human
8%
Chronic Atrial Fibrillation
8%
Atrioventricular Nodal Reentry Tachycardia
8%
Antiplatelet
7%
Dronedarone
7%
Ischemic Heart Disease
7%
New-Onset Atrial Fibrillation
7%
Atenolol
7%
Antiarrhythmic Agent
7%
Sudden Cardiac Death
7%
Angiotensin II
7%
All Cause Mortality
6%
Cohort Study
6%
Bradycardia
6%
Propafenone
6%
Hypertrophic Cardiomyopathy
6%
Supraventricular Tachycardia
6%
Clinical Feature
5%
Placebo
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Clopidogrel
5%
Coronary Risk
5%
Heart Ventricle Fibrillation
5%
Brain Ischemia
5%
Zebra Fish
5%
Heart Rate Turbulence
5%
Moroxydine
5%
Mitral Valve Disease
5%
Tumor Necrosis Factor
5%
Sodium Channel
5%
Heart Arrhythmia
5%
